MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT AND ANNOUNCES CLOSING UNDER SHARE...

Sep 13, 2022, 16:50 ETMINDCURE Announces Financial Results for Fiscal 2022VANCOUVER,...

Psilera Receives First Patent Allowance for Transdermal Patch Formulations

Revive Therapeutics Announces Submission of Amended Phase 3 COVID-19 Study Protocol...

Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of...

Small Pharma Enters Into Automatic Share Purchase Plan

Numinus provides update on acquisition integration and announces new client financing...

Nature Biotechnology Selects Delix Therapeutics as a Leading Biotech Start-Up

PT355 – Ifetayo Harvey – The Drug War, Caregiving, and Blue...

Algernon Pharmaceuticals Receives Approval for Groundbreaking Phase 1 DMT Human Stroke...

Load more